renal cell carcinoma tumor sections (Novus Biologicals)
Structured Review

Renal Cell Carcinoma Tumor Sections, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/renal+cell+carcinoma+tumor+sections/Kidney+Tissue+Slides+(Renal+Cell+Carcinoma)-+Paraffin/10__1158_slash_0008___5472__can___04___4313-99-6-20
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor β Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model"
Article Title: Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor β Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model
Journal: Cancer Research
doi: 10.1158/0008-5472.can-04-4313
Figure Legend Snippet: Figure 1. PDGF-D is overexpressed in human renal cell carcinoma samples. Normal kidney tissue in the tissue microarray stains with anti–PDGF-D antibody in collecting tubes (A-D). In clear cell type (E and G), granular cell type (F), and granular and clear cell type (H) tumor tissues, PDGF-D stains strongly and homogenously. The arrow indicates positive staining. I, isotype control staining of the tumor tissues. Antigoat immunoglobulin stains negatively of the tumor tissues. Bar, 50 Am.
Techniques Used: Microarray, Staining, Control
Related Articles
Microarray:Article Title: Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor β Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model Article Snippet: PDGF-D antibody does not cross-react with recombinant human PDGF-C protein (R&D Systems) as determined by dot blot. .. Tissue microarray slides bearing 50 human |